Tyra Biosciences (TYRA) Share-based Compensation (2020 - 2026)

Tyra Biosciences has reported Share-based Compensation for 7 years, with the latest figure at $7.8 million in Q1 2026.

• For the quarter ending Q1 2026, Share-based Compensation rose 112.08% year-over-year to $7.8 million; the trailing twelve-month figure through Mar 2026 stood at $26.0 million (down 7.26% YoY), and the FY2025 full-year result was $28.0 million, up 22.83% from the prior year.
• Share-based Compensation for Q1 2026 stood at $7.8 million, up from $7.6 million in the prior quarter.
• The five-year high for Share-based Compensation was $12.3 million in Q4 2024, with the low at -$1.0 million in Q4 2023.
• Historically, Share-based Compensation has averaged $4.4 million across 5 years, with a median of $4.0 million in 2022.
• Annual changes were most pronounced in 2022 — Share-based Compensation jumped 2182.76% — and 2023, when it plunged 135.72%.
• Tyra Biosciences' Share-based Compensation stood at $2.9 million in 2022, then sank by 135.72% to -$1.0 million in 2023, then jumped by 1283.93% to $12.3 million in 2024, then slumped by 38.0% to $7.6 million in 2025, then grew by 2.88% to $7.8 million in 2026.
• The last three Share-based Compensation figures came in at $7.8 million (Q1 2026), $7.6 million (Q4 2025), and $4.1 million (Q3 2025), per Business Quant data.